期刊
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN
卷 25, 期 7, 页码 607-610出版社
SPRINGER
DOI: 10.1007/s10822-011-9451-z
关键词
Fragment-based drug design; Biologics; Off-shoring; Outsourcing
Fragment-based lead discovery has undergone remarkable changes over the last 15 years. During this time, the pharmaceutical industry has changed dramatically as well, and continued evolution of the industry is assured. These changes present many challenges but also several opportunities for executing fragment-based drug design. This article will explore some of the more significant changes in the industry and how they may affect future discovery efforts related to fragment-based initiatives.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据